J. Norman

发表

Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers.

J. Maguire, D. Doolan, P. Hobart, 2000, Vaccine.

Induction in Humans of CD8+ and CD4+ T Cell and Antibody Responses by Sequential Immunization with Malaria DNA and Recombinant Protein1

S. Hoffman, D. Carucci, P. de la Vega, 2004, The Journal of Immunology.

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.

S. Hoffman, D. Carucci, Joe D. Cohen, 2004, Vaccine.

Recombinant Protein Immunization with Malaria DNA and Cell and Antibody Responses by Sequential T + and CD4 + Induction in Humans of CD8

Patricia De la Vega, S. Hoffman, D. Carucci, 2004 .

Safety, tolerability, and lack of antibody responses after administration of a PfCSP DNA malaria vaccine via needle or needle-free jet injection, and comparison of intramuscular and combination intramuscular/intradermal routes.

S. Hoffman, E. Gorak, Sanjai Kumar, 2002, Human gene therapy.

Development of improved vectors for DNA-based immunization and other gene therapy applications.

P. Hobart, P. Felgner, C. Wheeler, 1997, Vaccine.

Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA.

S. Hoffman, A. Steinberg, D. Klinman, 1995, Journal of immunology.

Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits.

S. Hoffman, P. Hobart, S. Parker, 1999, Human gene therapy.

The development of a multivalent DNA vaccine for malaria

S. Hoffman, M. Gardner, J. Sacci, 2004, Springer Seminars in Immunopathology.

Toward clinical trials of DNA vaccines against malaria

S. Hoffman, D. Doolan, P. Hobart, 1997, Immunology and cell biology.

Nucleic Acid Malaria Vaccines

D. Doolan, P. Hobart, K. Gowda, 1995 .

Nucleic acid malaria vaccines. Current status and potential.

S. Hoffman, D. Doolan, P. Hobart, 1995, Annals of the New York Academy of Sciences.

Boosting of DNA Vaccine-Elicited Gamma Interferon Responses in Humans by Exposure to Malaria Parasites

S. Hoffman, D. Freilich, T. Richie, 2005, Infection and Immunity.

Plasmid DNA malaria vaccine: the potential for genomic integration after intramuscular injection.

S. Hoffman, P. Hobart, S. Parker, 1999, Human gene therapy.

Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.

S. Hoffman, J. Aguiar, D. Doolan, 1997, Vaccine.

Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine.

S. Hoffman, D. Doolan, P. Hobart, 1998, Science.

Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine

S. Hoffman, D. Carucci, D. Doolan, 2001, Proceedings of the National Academy of Sciences of the United States of America.

A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha.

K. Barnhart, H. Horton, S. Parker, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA

S. Hoffman, D. Freilich, J. Aguiar, 2012, Human vaccines & immunotherapeutics.

Killer Whale Predation on Sea Otters Linking Oceanic and Nearshore Ecosystems

Denise L. Doolan, D. Doolan, P. Hobart, 1998 .

DNA vaccines for malaria: the past, the present, & the future.

S. Hoffman, D. Doolan, P. Hobart, 1997, The Indian journal of medical research.

Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens.

M. Ferrari, C. Wheeler, L. Sukhu, 2001, Vaccine.

An improved plasmid DNA expression vector for direct injection into skeletal muscle.

K. Barnhart, M. Liebert, P. Hobart, 1996, Human gene therapy.